Index of artpub/2023/300097/

Puertas, Borja
Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients
2023
https://ddd.uab.cat/record/300097